Rivus Pharmaceuticals
PrivateLast Round
Series B
Sep 22, 2022
Total Funding Raised
$167M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Rivus Pharmaceuticals is a biopharmaceutical company that develops controlled metabolic accelerators aimed at enhancing cardio-metabolic health through oral small-molecule therapeutics targeting the root causes of metabolic and cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rivus Pharmaceuticals Comparables
Compare Rivus Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OrsoBio | 85% | |
| Roche Holding | 82% | |
| Terns Pharmaceutical | 81% |
Rivus Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 22, 2022 | ||||
| Series A | Jul 20, 2021 |
Key People
Founding team and executive leadership
Rivus Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series B, Series A |
| Bain Capital Life Sciences | Series B |
| RA Capital Management | Series B |
| BB Biotech | Series B |
| Medicxi | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 53% MoM, reaching 4.2K.
- Jun 19, 2026
Monthly visitors increased 114% MoM.
Rivus Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rivus Pharmaceuticals's valuation, stock price, and market status.
Is Rivus Pharmaceuticals a public or private company?
Rivus Pharmaceuticals is a private company.
What is the current stock price of Rivus Pharmaceuticals?
Rivus Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Rivus Pharmaceuticals worth (valuation)?
Valuation information for Rivus Pharmaceuticals is not publicly available.
Can I buy Rivus Pharmaceuticals stock?
Rivus Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rivus Pharmaceuticals's last funding round?
Rivus Pharmaceuticals's most recent funding round was Series B on September 22, 2022.
Who are the main investors in Rivus Pharmaceuticals?
Key investors in Rivus Pharmaceuticals include Longitude Capital, RA Capital Management, Medicxi.
Will Rivus Pharmaceuticals IPO soon?
No public IPO plans have been announced for Rivus Pharmaceuticals.
How can I track Rivus Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rivus Pharmaceuticals's secondary market activity and sign up for updates.